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1. Introduction 
Osteoarthritis (OA) is a degenerative articular disease primarily observed in older adults, 
and is the leading cause of physical disability and impaired quality of life. OA is 
characterized by softening, fibrillation, erosion, defect of the articular cartilage, bone 
hypertrophy at the margins with osteophyte formation, subchondral sclerosis, and chronic 
inflammation of the synovial membrane and joint capsule (Zhang et al., 2010). 
These alterations are thought to be caused by biochemical and biomechanical factors leading 
to a failure in the balance of synthesis and degradation (Martel-Pelletier et al., 2010). 
Pathogenesis of OA is based on an imbalance of the functional requirements and 
morphologic alterations, and these statuses progressively and chronically evoke subsequent 
alterations (Lorenz et al., 2005). 
Although the etiology of OA is not completely understood, the accompanying biochemical, 
structural, and metabolic alterations of the articular cartilage have been well described (de 
Seny et al., 2011; Kraus 2010; Reeves et al., 2011; Sobczak et al., 2010). Recently, it has been 
revealed that proteolytic enzymes, cytokines, biomechanical stress, and altered genetics are 
involved in its pathogenesis, and proteolytic activity is particularly important in regards to 
the morphologic alterations of the articular structures, and is considered as an internal-
factor of the disease (Takei et al., 1999; Kevorkian et al., 2004). It has been suggested that 
proteolytic activity in the constituent of the joint, such as synovium, joint fluid, cartilage, is 
continuously involved in the articular alterations of the disease, as its progression is 
gradual.  
Although it is extremely difficult to accurately predict future articular OA alterations, it is 
possible to evaluate the present phenomenon, which may lead to speculation of possible 
further alterations by evaluating proteolytic activity in the joint. 
2. Evaluation of in vivo proteolytic activiy 
2.1 In situ zymography 
There have been many studies of proteolytic activity, using gelatin zymography. This 
method is a valuable and effective tool for examining and analyzing proteolytic activity, 
as gelatin degrades over the course of the disease (Hattori et al., 2003; Cha et al., 2004; Sun 
et al., 2003). However, most current zymography methods are used to qualitatively 
examine this activity, and are thus not adequate for histological evaluation or 
quantification. 
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In situ zymography was developed to determine the in vivo proteolytic activity and 
determine its histological location. However, this method has only been used to 
demonstrate a qualitative analysis as the gelatin does not sufficiently coat the film with a 
uniform thickness of substrate to allow precise quantification of the in vivo proteolytic 
activity (Senzaki et al., 2000; Yi et al., 2001; Galis et al., 1995; Viemard-Barone et al., 2000; 
Goodall et al., 2001). 
A newly method, “film in situ zymography (FIZ)”, has been developed specially to evaluate 
the histological distribution the in vivo proteolytic activity (Ikeda et al., 2000; Takano et al., 
2001; Zheng et al., 2002; Kaji et al., 2003) .  
This new method works by applying unfixed frozen tissues (or fluid) to the recently 
developed FIZ film (Fuji Film. Co., Tokyo, Japan) which is uniformly coated with cross-bridge 
gelatin at a thickness of 7 μm. In our study, the synovial tissue specimens were embedded in 
Tissue-Tek OCT Compound (Lab-Tek Products, Elkhart, IN, USA) and frozen in the cryostat’s 
refrigerated chamber. Then, frozen sections were cut at 4 μm, and applied to the FIZ film, 
followed by flushing with water for a few seconds. After incubation for 6 hours at 37°C, the 
film was stained with 0.2% Ponceau solution (which is commonly used for protein staining), 
(Sigma-Aldrich, St. Louis, MO, USA) for 3 minutes and fixed with 1% acetate for 5 minutes. 
After flushing with water for 15 minutes, the film was stained with hematoxylin for nuclear 
staining. Gelatinolyzed areas caused by the proteolytic activity in the synovium were detected 
as pale in color, and non-gelatinolyzed areas were stained red (Figure 1). In several studies, 
this method was successful in achieving reproducible quantification of gelatinolyed areas 
(Iwata et al., 2001; Furuya et al., 2001; Yamanaka et al., 2000). 
 
 
Fig. 1. Film in situ zymography of OA synovium. Arrows indicate the proteolytic lesions as 
pale in color in the Ponceau-stained FIZ film.  
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2.2 Quantification by image analyzer 
Furthermore, it is possible to quantify the degree of this activity using a digital image 
analyzer (Image Processor for Analytical Pathology, IPAP, Sumitomo Tech, Osaka, Japan). 
The IPAP system is comprised of a conventional microscope, a CCD color video camera, an 
IBM-compatible microcomputer and a specialized image analysis board, Matrox Image-1280 
(Dorval, Quevec, Canada) to convert microscopic photographic images into digital images, 
and allows us to analyze many samples, fields and parameters (Figure 2). For each Ponceau-
stained FIZ film image, the analyzer can measure the approximate optical density of 
gelatinolyzed area as optical density of gelatinolyzed area (ODG) and ratio of gelatinolyzed 
area (RGA). The ODG is the mean optical density of the red-stained component at 50 
random points in the gelatinolyzed area. The RGA is the ratio of the gelatinolyzed area to 
the entire synovium stained on the FIZ films as background reference (ODG and RGA were 
measured blindly at a magnification of ×4). As such, implementing both FIZ and IPAP 
enable the histological evaluation and quantification of the in vivo proteolytic activity to 
analyze the gelatinolyzed area (Uzuki et al., 1999; Yoshida et al., 2009). 
 
 
Fig. 2. IPAP system. This system is comprised of a microscope, a CCD color video camera 
and an analyzing computer for converting microscopic photographic images into digital 
images. 
3. In vivo proteolytic activity on OA synovium 
It was revealed through FIZ the in vivo proteolytic activity on OA synovium was mainly 
distributed in the layer of the lining rather than in the stroma, although this histological 
feature is predominant and consisted of uniform fibrous proliferation with chronic 
inflammation. Furthermore, distribution of the proteolytic area in rheumatoid arthritis (RA) 
synovium, which showed obvious inflammatory changes, also detected in layer of the lining 
(Yoshida et al., 2009). 
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Comparing the in vivo proteolytic activity using FIZ and IPAP, there was a significant 
difference between OA and RA synovium in regards to the ODG (Figure 3) and RGA 
(Figure 4)(Yoshida et al., 2009). These findings suggest that there is also a difference on the 
proteolytic potential per one active-cell and the proteolytic-cell number between OA and RA 
synovium, and this might reflect that the articular alteration in OA is less progressive than 
in RA. 
Furthermore, the proteolytic area is mostly localized in the layer of the lining and similar to 
both OA and RA articular disease, although they have different degrees of activity. The 
proteolytic area is constantly exposed to the articular space, and this finding suggests that 
the in vivo proteolytic activity in synovium might be affected in the interaction with the 
constituents of articular space as an internal-factor of the articular alterations. 
 
 
Fig. 3. Optical density of the gelatinolyzed area (ODG) as produced by FIZ and IPAP the 
synovium of OA and RA. OA synovium had a significantly higher ODG (0.864±0.037) than 
RA synovium (0.758±0.019). All OA cases were classified as grade 4 using Kellgren and 
Lawrence classification and all RA cases were classified as stage IV using the Steinbrocker 
classification. 
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Fig. 4. Ratio of gelatinolyzed areas (RGA) as produced by FIZ and IPAP the synovium of 
OA and RA. The synovium of OA had a significantly lower RGA (3.5±1.1%) than RA 
synovium (9.7±3.1%). All OA cases were classified as grade 4 using Kellgren and Lawrence 
classification and all RA cases were classified as stage IV using the Steinbrocker 
classification. 
In examination of enzyme expression by immunohistochemistry using serial sections, 
matrix metalloproteinase (MMP)-2, MMP-9, also known as gelatinase-A and -B, were mainly 
expressed by fibroblast- or macrophage-like cells of the synovial-lining layer (Figures 5a and 
5b). Interestingly, these same cells also expressed tissue inhibitor of metalloproteinase 
(TIMP) -1 and TIMP-2 (Figures 5c and 5d). In addition, the distribution of cells expressing 
MMPs and TIMPs corresponded to the proteolytic areas detected by FIZ investigation 
(Figure 5a, 5b, 5c, and 5d as serial sections showed the expression of the enzymes by 
immunohistochemisty in lining layer of RA synovium). These findings indicate that 
synovial cells simultaneously produce proteolytic enzymes and their inhibitors, and suggest 
that the in vivo proteolytic activity might be dependent on “imbalances” in enzymes-
inhibitors production of the individual cells. 
Utilizing FIZ and IPAP may further help to understand biological enzymatic activity on 
articular manifestations of OA. 
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Fig. 5a. Expression of MMP-2 by immunohistochemistry. 
 
 
 
 
 
 
Fig. 5b. Expression of MMP-9 by immunohistochemistry. 
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Fig. 5c. Expression of TIMP-1 by immunohistochemisry. 
 
 
 
 
 
 
Fig. 5d. Expression of TIMP-2 by immunohistochemisry. 
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